BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang YQ, Huang C, Ye PJ, Long JR, Xu CH, Liu Y, Ling XL, Lv SY, He DX, Wei H, Yu CY. Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo. J Control Release 2022;347:400-13. [PMID: 35577150 DOI: 10.1016/j.jconrel.2022.05.024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Wang D, Liu H, Liu L, Li S, Zhou Z, Lu L, Liu X, He L, He D, Yu CY, Wei H. A Clinically Translatable Ternary Platinum(IV) Prodrug for Synergistically Reversing Drug Resistance  . J Med Chem 2023;66:4045-58. [PMID: 36897884 DOI: 10.1021/acs.jmedchem.2c01924] [Reference Citation Analysis]
2 Liang Y, Wang PY, Li YJ, Liu ZY, Wang RR, Sun GB, Sun HF, Xie SY. Multistage O(2)-producing liposome for MRI-guided synergistic chemodynamic/chemotherapy to reverse cancer multidrug resistance. Int J Pharm 2023;631:122488. [PMID: 36521638 DOI: 10.1016/j.ijpharm.2022.122488] [Reference Citation Analysis]
3 Jiang M, Liu H, Wang J, Li S, Zheng Z, Wang D, Wei H, Yu C. Optimized aptamer functionalization for enhanced anticancer efficiency in vivo. International Journal of Pharmaceutics 2022;628:122330. [DOI: 10.1016/j.ijpharm.2022.122330] [Reference Citation Analysis]